Conducting a Successful End-of-Phase 2 Meeting with the FDA

Conducting a Successful End-of-Phase 2 Meeting with the FDA 2015-09-18 2015-09-18 An End-of-Phase 2 (EOP2) meeting is a meeting between the US FDA and the sponsor of a clinical development program after the completion of the Phase 2 study and prior to the start of the Phase 3 study. It is mo
Source: AAPS Calendar - Category: Drugs & Pharmacology Source Type: events